These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9641002)

  • 1. Low-dose venlafaxine treatment in panic disorder.
    Papp LA; Sinha SS; Martinez JM; Coplan JD; Amchin J; Gorman JM
    Psychopharmacol Bull; 1998; 34(2):207-9. PubMed ID: 9641002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
    Pollack MH; Worthington JJ; Otto MW; Maki KM; Smoller JW; Manfro GG; Rudolph R; Rosenbaum JF
    Psychopharmacol Bull; 1996; 32(4):667-70. PubMed ID: 8993089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot open-label study of nefazodone in panic disorder.
    Bystritsky A; Rosen R; Suri R; Vapnik T
    Depress Anxiety; 1999; 10(3):137-9. PubMed ID: 10604088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label trial of venlafaxine in adults with attention deficit disorder.
    Adler LA; Resnick S; Kunz M; Devinsky O
    Psychopharmacol Bull; 1995; 31(4):785-8. PubMed ID: 8851654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
    Findling RL; Schwartz MA; Flannery DJ; Manos MJ
    J Clin Psychiatry; 1996 May; 57(5):184-9. PubMed ID: 8626348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine XR in the treatment of anxiety.
    Hackett D
    Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
    Hedges D; Reimherr FW; Rogers A; Strong R; Wender PH
    Psychopharmacol Bull; 1995; 31(4):779-83. PubMed ID: 8851653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.
    March JS; Entusah AR; Rynn M; Albano AM; Tourian KA
    Biol Psychiatry; 2007 Nov; 62(10):1149-54. PubMed ID: 17553467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine in the treatment of children and adolescents with major depression.
    Mandoki MW; Tapia MR; Tapia MA; Sumner GS; Parker JL
    Psychopharmacol Bull; 1997; 33(1):149-54. PubMed ID: 9133767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].
    Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG
    Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine in social phobia.
    Kelsey JE
    Psychopharmacol Bull; 1995; 31(4):767-71. PubMed ID: 8851651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
    Simon JS; Aguiar LM; Kunz NR; Lei D
    J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-longitudinal study of the effect of dissociative symptoms on the response of patients with panic disorder to venlafaxine.
    Ural C; Belli H; Tabo A; Akbudak M
    Compr Psychiatry; 2015 Feb; 57():112-6. PubMed ID: 25492225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of venlafaxine in trichotillomania: interim phase I results.
    Ninan PT; Knight B; Kirk L; Rothbaum BO; Kelsey J; Nemeroff CB
    Psychopharmacol Bull; 1998; 34(2):221-4. PubMed ID: 9641004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.